Tag: a-new-treatment

Column: Things Ken Burns Gets Wrong About Cancer

| April 10, 2015 | 0 Comments

It’s almost mandatory that any documentary or news segment describing a new treatment for cancer must pulse with the twin themes of tragedy and hope.

Continue Reading

New MS Treatment Giving Hope To Patients

| April 9, 2015 | 0 Comments

There's a new treatment for MS patients who've tried everything and have yet to find something that works for them.

Continue Reading

The Three Things Ken Burns Gets Wrong About Cancer

| April 3, 2015 | 0 Comments

It’s almost mandatory that any documentary or news segment describing a new treatment for cancer must pulse with the twin themes of tragedy and hope. The latest Ken Burns documentary, Cancer: The Emperor of All Maladies, captures and surpasses these hallmarks of the genre. Viewing the PBS series this week left me without what I believe is a current real-world assessment of the state of cancer.

Continue Reading

MD Anderson, Astellas Pharma sign option agreement for monoclonal antibody drug targeting acute myeloid leukemia

| April 3, 2015 | 0 Comments

( University of Texas M. D. Anderson Cancer Center ) The University of Texas MD Anderson Cancer Center and Astellas Pharma Inc.

Continue Reading

MD Anderson, Astellas Pharma Sign Option Agreement

| April 3, 2015 | 0 Comments

The University of Texas MD Anderson Cancer Center and Astellas Pharma Inc.

Continue Reading

New Calgary cancer centre announced

| March 30, 2015 | 0 Comments

Cancer patients in Calgary are getting a new treatment centre at the South Health Campus.

Continue Reading

Prostate cancer research breakthrough from Sydney's Centenary Institute

| March 25, 2015 | 0 Comments

Researchers from the Origins of Cancer group have opened the door to a new treatment for prostate cancer which can starve cancer cells.

Continue Reading

Nanotechnology platform shows promise for treating pancreatic cancer

| March 24, 2015 | 0 Comments

Scientists at UCLA's California NanoSystems Institute and Jonsson Comprehensive Cancer Center have combined their nanotechnology expertise to create a new treatment that may solve some of the problems of using chemotherapy to treat pancreatic cancer.

Continue Reading

Hong Kong Authority Approves Abraxane(R) as First-Line Treatment For Late-Stage Pancreatic Cancer

| March 18, 2015 | 0 Comments

HONG KONG, March 18, 2015 /PRNewswire/ — Celgene announced today that a new treatment option for late-stage pancreatic cancer is now available for use in Hong Kong. Approved by the Department of Health, Abraxane® (paclitaxel formulated as albumin-bound nanoparticles) is indicated for use in combination with gemcitabine, another chemotherapy drug, as first-line treatment for patients with late …

Continue Reading

Sirtex plummets on mixed study results

| March 17, 2015 | 0 Comments

Shares in biotech Sirtex Medical have more than halved after a treatment under development for colorectal cancer produced mixed results.

Continue Reading